| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,447 | 16,110 | 15,814 | 16,244 | | Cost of Revenue | 1,471 | 1,373 | 1,408 | 2,019 | | | Gross Profit |
-
| 14,737 | 14,406 | 14,225 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,441 | 8,264 | 7,207 | 6,750 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,435 | 1,036 | 1,535 | 2,544 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 5,437 | 5,664 | 4,931 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,100 | 5,437 | 5,664 | 4,931 | | Interest Expense | 309 | 431 | 361 | 195 | | Income Before Tax | 5,791 | 5,006 | 5,303 | 4,736 | | Income Tax Expense | 2,190 | 1,873 | 2,074 | 1,943 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,601 | 3,133 | 3,229 | 2,793 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,601 | 3,133 | 3,229 | 2,793 | | Preferred Stock And Other Adjustments |
-
|
-
| (1,299) | (113) | | | Net Income Applicable To Common Shares | $3,601 | $3,133 | $1,930 | $2,680 |
|
0.02% Nasdaq 0.00%
Income Statement
